BCL2 and neoplasm: Notably, the loss of methylation of this VavP-Bcl2+Aicda cytosine methylation signature results in an increase in intra-tumor heterogeneity compared to the VavP-Bcl2 tumors (paired Wilcoxon's test P < 1e−300; Fig. 2e).